MetaCap

Liminatus Pharma Earnings

NASDAQ: LIMNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.51-0.30 (-10.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 26, 2026

Fiscal period

Sep/2026

Liminatus Pharma earnings summary

Liminatus Pharma is scheduled to report Sep/2026 earnings on Nov 26, 2026. In its most recent report on Nov 19, 2026 (Sep/2026), LIMN posted EPS of $-3.50.

Summary generated from market data by MetaCap's automated system. Methodology

LIMN earnings history

Liminatus Pharma reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 19, 2026—$-3.50——
Nov 12, 2026—$-3.50—-16.1%
Aug 14, 2026—$-0.03——
May 15, 2026—$-0.03——
Mar 31, 2026—$-0.34——
Nov 14, 2025—$-0.07——
Oct 6, 2025—$0.00——
Jun 2, 2025—$-0.02——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related